ZUVAMOR Trademark of AstraZeneca UK Limited - Serial Number 76006368

ZUVAMOR Trademark

Trademark Overview

On Tuesday, March 21, 2000, a trademark application was filed for ZUVAMOR with the United States Patent and Trademark Office. The USPTO has given the ZUVAMOR trademark a serial number of 76006368. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 21, 2012. This trademark is owned by AstraZeneca UK Limited. The ZUVAMOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system; cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, anesthesia, oncology, infection, inflammation, urology, gynaecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes

General Information

Serial Number	76006368
Word Mark	ZUVAMOR
Filing Date	Tuesday, March 21, 2000
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, September 21, 2012
Registration Number	3038655
Registration Date	Tuesday, January 10, 2006
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, October 18, 2005

Trademark Statements

Goods and Services

Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system; cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, anesthesia, oncology, infection, inflammation, urology, gynaecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, September 21, 2012
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	AstraZeneca UK Limited
Party Type	30 - Original Registrant
Legal Entity Type	16 - Limited Liability Company
Address	London W1Y 6LN

Party Name	AstraZeneca UK Limited
Party Type	20 - Owner at Publication
Legal Entity Type	16 - Limited Liability Company
Address	London W1Y 6LN

Party Name	AstraZeneca UK Limited
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	London W1Y 6LN

Trademark Events

Event Date	Event Description
Friday, September 21, 2012	CANCELLED SEC. 8 (6-YR)
Tuesday, July 31, 2007	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 31, 2007	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 10, 2006	REGISTERED-PRINCIPAL REGISTER
Tuesday, October 18, 2005	PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2005	NOTICE OF PUBLICATION
Wednesday, August 17, 2005	LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 5, 2005	ASSIGNED TO LIE
Thursday, August 4, 2005	APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 26, 2005	AMENDMENT FROM APPLICANT ENTERED
Monday, July 11, 2005	CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 21, 2005	1(B) BASIS DELETED; NEW BASIS REQUESTED
Thursday, February 3, 2005	NOTICE OF ALLOWANCE CANCELLED
Monday, July 11, 2005	PETITION TO DIRECTOR - GRANTED
Thursday, February 3, 2005	PETITION TO DIRECTOR RECEIVED
Thursday, February 3, 2005	PAPER RECEIVED
Wednesday, September 29, 2004	EXTENSION 5 GRANTED
Sunday, September 19, 2004	EXTENSION 5 FILED
Monday, September 20, 2004	TEAS EXTENSION RECEIVED
Wednesday, July 21, 2004	CASE FILE IN TICRS
Saturday, March 27, 2004	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 22, 2004	EXTENSION 4 GRANTED
Friday, March 12, 2004	EXTENSION 4 FILED
Friday, March 12, 2004	TEAS EXTENSION RECEIVED
Friday, September 26, 2003	EXTENSION 3 GRANTED
Thursday, September 18, 2003	EXTENSION 3 FILED
Thursday, September 18, 2003	TEAS EXTENSION RECEIVED
Wednesday, May 7, 2003	EXTENSION 2 GRANTED
Tuesday, March 18, 2003	EXTENSION 2 FILED
Tuesday, March 18, 2003	TEAS EXTENSION RECEIVED
Friday, September 27, 2002	EXTENSION 1 GRANTED
Tuesday, September 17, 2002	EXTENSION 1 FILED
Tuesday, March 19, 2002	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 25, 2001	PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2001	NOTICE OF PUBLICATION
Tuesday, September 4, 2001	APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 4, 2001	REINSTATED
Friday, March 23, 2001	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, August 11, 2000	NON-FINAL ACTION MAILED

Related Keywords

zuvamor system pharmaceutical preparations substances treatment prevention nervous infection oncology anesthesia